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Objective. High intraluminal pressure during ureterorenoscopy (URS) increases risk of infectious and haemorrhagic complications.
Intrarenal pressure may be reduced by the use of ureteral access sheaths (UASs), which on the other hand may cause ureteral
damage. We have previously shown that the 𝛽-agonist isoproterenol (ISO), when administered topically in the irrigation fluid, is
able to inhibit ureteral muscle tone and lower intrarenal pressure during URS. The aim of this study was to examine the effect of
ISO on the success rate of UAS insertion in a porcine model.Materials and Methods. 22 pigs in which a UAS could not initially be
placed were randomized to endoluminal irrigation with either ISO (0.1𝜇g/mL) or saline before a new insertion trial. Subsequently,
it was registered whether the UAS could be passed without resistance. During extraction of the sheath, any ureteral lesions were
characterized ureteroscopically using the PULS classification system. Surgeons were blinded to randomization. Results. In the ISO
group, the observed effect of irrigation was 63% successful UAS insertions, compared to 27% in the saline group. No serious lesions
(<PULS grade 2) were observed in the ISO group. Conclusions. Endoluminal irrigation with ISO may facilitate UAS insertion and
potentially decrease UAS related ureteral lesions.
1. Introduction
Ureteral access sheaths (UASs) are increasingly being used
for ureterorenoscopic procedures (URS). The use of UAS
has been shown to decrease intrarenal pressure during URS,
thereby potentially reducing risk of septic and haemorrhagic
complications [1, 2]. On the other hand, several recent
reports have documented UAS usage to be associated with
ureteral damage, which subsequently may result in stricture
formation and loss of kidney function [3, 4].Thus, UAS usage
may be a double-edged sword: on the one hand diminishing
risks related to irrigation and on the other hand increasing
risks related to access in a narrow ureter [5]. However, the
access related injuries might be related to not only the limited
size of the ureter, but also the dynamics of the organ [4, 6].We
have previously shown that the𝛽-agonist isoproterenol (ISO),
when administered locally in a 0.1𝜇g/mL saline solution at an
irrigation rate of 8mL/min, was able to inhibit the ureteral
muscle tone and lower the pressure in the upper urinary
tract significantly during ureterorenoscopy without causing
systemic adverse effects [7–10].
We present a randomized feasibility trial of the effect of
adding ISO to the irrigation fluid for successful UAS insertion
in a porcine model.
2. Materials and Methods
The study was performed on 22 anaesthetized female pigs
weighing 55 kg. The pigs were fed a standard diet during
breeding. Before the study, they had access to water but were
fasted 12 hours prior to anaesthesia.
After premedicationwith azaperone (4mg/kg) andmida-
zolam (4mg/kg), anaesthesia was induced by propofol (4–
20mg/kg) and maintained with sevoflurane (1.2 MAC)
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and fentanil (0.03mg/kg/h). The pigs were orotracheally
intubated and mechanically ventilated (GE Healthcare S5
Avance). Hydration was maintained by administration of
saline (9 g/L sodium chloride, 10mL/kg/h) at a temperature
of 37∘C through an ear vein.
The 22 pigs were randomized into two groups each of
11 individuals. Each group was assigned to saline irrigation
fluid as follows: ISO group, addition of 0.1mg/mL ISO, or
saline group, no ISO added. The investigators were blinded
to randomization.
A cystoscope was inserted through the urethra into
the bladder. A ureteral catheter (Selectip, Bard Medical,
Covington, USA) was placed in the distal part of the ureter
and retrograde pyelography was performed to visualize the
anatomy of the upper urinary tract. A hydrophilic guidewire
(Sensor, Boston Scientific, Marlborough, MA, USA) was
placed via the ureteral catheter, through the ureter, to the
renal pelvis, and the cystoscope was removed.
Over the guidewire an attempt of insertion of a UAS
(NavigatorUreteral Access Sheath, Boston Scientific, Marl-
borough, MA, USA) 13/15 Fr. was made. The insertion was
performed under fluoroscopic guidance. Advancement of the
UAS was stopped, when the surgeon according to clinical
experience subjectively felt that resistance was too great to
proceed. The position of the tip of the UAS in the ureter
was registered by fluoroscopy, and a distance mark was made
on the sheath at the level of the external urethral meatus in
order to locate the area of ureteral resistance. The UAS was
removed and the distance mark was transferred to a dual
lumen ureteral catheter 10 Fr. (Cook Medical, Bloomington,
IN, USA), which was then inserted over the guidewire until
the mark was at the level of the external urethral meatus and
the tip of the catheter at the area of ureteral resistance.
The irrigation fluid was mounted on the second channel
of the dual lumen catheter and administered with a pump
at a constant irrigation rate of 8mL/min for 5 minutes.
Subsequently, a new attempt wasmade to insert the UAS, and
it was registered if insertion proximal to the resistance was
possible (= full effect) or not (= no effect).
Finally, a semirigid ureteroscope was inserted through
the UAS, and during retraction of the sheath the ureter was
inspected for visible lesions, which were characterized and
registered using the PULS classification system [11].
In all pigs, UAS insertion was performed on the left ureter
primarily. If no resistance was found, insertion was tried
on the right ureter. If there was no resistance to the UAS
on either side, ureteral dilators 16−18 Fr. (Boston Scientific,
Marlborough, MA, USA) were inserted successively until
resistance was met. If there was no resistance to these either,
the pig was excluded from the study and replaced by a new
pig that was assigned to the same treatment according to
randomization.
During every UAS insertion, measurements of the push-
ing forces were registered by a force meter (Fourier Force
sensor) attached to the UAS and connected to a computer
with recording software (NovaLink datalogger and Multi-
Lab data analysis software) (Figures 1 and 2).The surgeonwas
blinded to the force measurement recordings. During retrac-
tion ofUAS, the ureter was inspectedwith a ureteroscope; any
Figure 1: Ureteral access sheath 13/15 Fr. attached to the digital force
meter.
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Figure 2: Forcemeasurements registered 10 times/second displayed
as graphic curves in MultiLab data analysis software. The highest
force (𝐹max) measured in newton (N) for more than 1 second was
marked on each of the curves, defining 𝐹max > 1 s as the maximum
force applied to the UAS during insertion.
ureteral lesions were evaluated and registered using the PULS
classification system [11].
Finally, the pigs were euthanized under anaesthesia with
20mL of pentobarbital, 200mg/mL.
Ethics. The National Ethical Committee for Animal Experi-
mentation (Copenhagen, Denmark) approved the study.
Statistics. The study was designed as two parallel single-
arm studies [12]. The lowest acceptable rate of success was
defined as 45% and the highest unacceptable success rate was
defined as 10%. According to this, sample size was calculated
as 11 in each arm. Within these definitions, observation
of 4 or more full-effect insertions equals a success rate of
at least 45%, whereas observation of less than 4 full-effect
insertions means that the success rate may be below 10%
[12]. Results were analysed with one-sample calculation of
proportions in each group as two single-arm studies, using
Stata software (StataCorp, Texas). Values are reported as
estimates of proportions (95% CI).
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Table 1: Effect of irrigation with NaCl/ISO on successful UAS
insertion in cases in which a UAS could not be placed initially.
Group Effect No effect Total
NaCl 3 (27%) 8 (73%) 11 (100%)
ISO 7 (64%) 4 (36%) 11 (100%)
3. Results
Normal upper urinary tract anatomy was found in all ani-
mals. In 5 cases, no resistance was found even to insertion of
an 18 Fr. ureteral dilator, and these animals were excluded and
replaced in order to obtain complete data from 22 individual
pigs. In 6 of the tested 22 pigs, the ISO/NaCl experiment
was completed using ureteral dilators due to no resistance
to UAS 13/15 Fr. placement. According to randomization, ISO
was administered in the irrigation fluid during 11 procedures
and pure saline in 11.
In the ISO group, 7 of 11 UASs (64%, 95% CI: 35–92%)
could be placed successfully, compared to 3 of 11 UASs (27%,
95% CI: 1–53%) in the saline group (𝜒2 = 2.9; 𝑝 = 0.8)
(Table 1). Thus, despite being not statistically significant in
this limited series, there was a trend towards a higher success
rate in the ISO irrigation group.
Pushing-force measurement curves were recorded on all
insertions of UAS 13/15 Fr. (Tables 2 and 3). The highest force
(𝐹max) measured for more than 1 second was marked on each
of the curves, defining 𝐹max > 1 s as the maximum effective
force applied to the UAS during insertion (Figure 2). The
mean𝐹max > 1 s in all preirrigationmeasurements was 5.34N.
Themean 𝐹max > 1 s in cases of successful UAS insertion after
ISO irrigation was 6.04N. The mean 𝐹max > 1 s in cases of
successful UAS insertion after NaCl irrigation was 6.33N. In
comparison, the mean 𝐹max > 1 s was 4.6N in the 6 cases
where there was no subjective resistance to UAS 13/15 Fr.
insertion.
There were no statistically significant differences in mean
𝐹max between groups.
All ureteral lesions were evaluated ureteroscopically
according to the PULS classification scale (Tables 2 and 3).
In 5 out of the 6 cases of successful UAS insertion after ISO
irrigation, we observed a total of 4 grade 1 lesions and 6 grade
2 lesions. In the 3 cases of successful UAS insertion after NaCl
irrigation, we observed a total of 4 grade 1 lesions and 1 grade
2 lesion.
In the 13 cases of unsuccessful secondary UAS insertion,
there were 6 grade 1, 3 grade 2, and 2 grade 3 lesions found.
Thus, the severity of lesions was lower in the ureters, in which
the secondary insertion was possible.
4. Discussion
This randomized feasibility study suggests that placement of
a UAS may be eased by use of endoluminal irrigation with
the ureteral smooth muscle relaxant ISO, thus potentially
decreasingUAS related ureteral injury and increasing efficacy
of retrograde ureterorenoscopic procedures.
Globally, indications for flexible ureterorenoscopy (fURS)
are currently expanding without high-level evidence (ran-
domized controlled trials) to support its superiority to other
treatment modalities [5]. In a lot of these procedures, UASs
are being used, due to alleged advantages such as facilitating
retrograde intrarenal access, lowering intrarenal pressure,
protecting the scope, and expediting stone extraction [13].
On the other hand, the use of UAS, which incontrovertibly
has to have a larger diameter than the scope itself, harbours a
risk of damaging the ureteral wall, as has been demonstrated
in several recent clinical series [3, 4, 6]. In these series, as
well as in another recent series [14], it was shown that pre-
JJ-stenting both increased efficacy of fURS and reduced com-
plication rates related to access. This is probably due to the
fact that prestenting suppresses the peristaltic mechanism,
transforming the ureter into an adynamic tube that is much
easier accessed with scopes and sheaths [5]. Thus, it is not
just the size of the ureter that limits access; the dynamics
of the organ (peristalsis) also influence access success. The
fact that the second insertion trial in the present study was
successful in some of the cases irrigated with saline may be
explained by spontaneous changes in the peristalsis of the
ureter in these cases. Current practice of today is to stent
the ureter, if access is not possible at the primary procedure
[14]. This is inconvenient and wasteful for the patient as
well as the healthcare system, since a second procedure
has to be scheduled. The present preliminary data suggest
that ISO irrigation potentially may reduce the number of
second procedures in more than 60% of cases. ISO in high
concentrationsmay have cardiovascular side effects; however,
we have in previous human trials shown that intraluminal
irrigation with ISO in the very low concentration used in this
trial (0.1𝜇g/mL) did not result inmeasurable changes in pulse
rate and bloodpressure, nor could ISObemeasured in venous
samples [7, 8].
UAS placement in the present study was monitored
with force measurements. The mean force needed to place
the UASs was equivalent in the saline and ISO groups,
documenting that the higher success rate in the ISO group
was not due to the surgeon using more force for advancing
the UAS.This is further documented by the fact that ureteral
lesions (grades 1+2) were not more prevalent in this group.
The use of the validated PULS grading system in this blinded,
randomized trial adds to the strength of the observations.
On the other hand, the main limitation of the study is that
inability to place the UAS was subjectively judged by the
surgeon. To some extent, the randomized design takes into
account this limitation, and the fact that the forces needed to
place/refrain from placement of the UASs were comparable
to previously published force measurements in UAS inser-
tion and semirigid ureteroscopy suggests that the subjective
sensation of unacceptable ureteral resistance is a fair and
universal parameter [15, 16]. The present study represents a
preliminary feasibility study in a porcine model, and, before
recommendation for clinical use, ISO for facilitating UAS
usage has to be evaluated in a controlled clinical trial. The
present data justify the notion that the methodology may be
transferred to human clinical trials.
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Table 2: Results of ISO irrigation group. 𝐹max > 1 s = the highest force measured in newton (N) for more than 1 second. In the ureteral lesion
column, more than one number indicates more than one lesion.
Study ID UAS/dilatorsize (Fr.)
Effect
(insertion)
𝐹max > 1 s before
irrigation (N)
𝐹max > 1 s after
irrigation (N)
Ureteral lesions
(PULS grade)
2 15 Yes 2.4 5.0 0
4 15 Yes 5.4 5.2 1
9 18 Yes 7.8 N/A 1 + 1 + 2 + 2
10 18 Yes 4.4 N/A 2
11 18 No 4.3 N/A 2 + 3
12 15 Yes 6.0 5.6 2
15 15 No 5.6 6.9 1 + 1
16 15 Yes 3.8 4.4 0
17 15 No 4.9 6.6 0
21 15 No 6.5 5.2 1 + 3
22 15 Yes 5.4 8.3 2 + 2 + 1
Table 3: Results of NaCl irrigation group. 𝐹max > 1 s = the highest force measured in newton (N) for more than 1 second. In the ureteral lesion
column, more than one number indicates more than one lesion.
Study ID UAS/dilatorsize (Fr.)
Effect
(insertion)
𝐹max > 1 s before
irrigation(N)
𝐹max > 1 s after
irrigation (N)
Ureteral lesions
(PULS grade)
1 15 No 4.9 6.1 0
3 15 No 6.2 7.2 3
5 15 Yes 6.4 7.0 1
6 18 No 4.7 N/A 2 + 2
7 15 No 4.8 5.7 0
8 15 Yes 5.3 7.0 2
13 15 No 5.6 5.1 0
14 15 Yes 4.7 4.9 1 + 1 + 1
18 18 No 3.3 N/A 1
19 18 No 3.2 N/A 1
20 15 No 7.6 9.8 1
5. Conclusions
Endoluminal irrigation with ISO (0.1𝜇g/mL) may facilitate
UAS insertion and potentially decrease UAS related ureteral
lesions.
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